SCHEMBL2008790

SCHEMBL2008790

CC(C)COC(=O)COc1ccc(C(=O)CN2Cc3cc(C#N)ccc3C2=O)cc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 1/20 0.39
ITGA2B P08514 1/20 0.39
MAPT P10636 4/20 0.38
PRMT5 O14744 1/20 0.37
WDR77 Q9BQA1 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
AOC3 Q16853 4/20 0.36
KDM4E B2RXH2 2/20 0.36
ALK Q9UM73 1/20 0.36
ALDH1A1 P00352 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2B Q13224 1/20 0.35
KDM1A O60341 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2008304 0.91 USP2 (0.38) ITGB3ITGA2BMAPTPRMT5WDR77
SCHEMBL2012689 0.90 ALK (0.45) ITGB3ITGA2BMAPTL3MBTL1AOC3
SCHEMBL2014017 0.89 ITGB3 (0.40) ITGB3ITGA2BMAPTPRMT5WDR77
SCHEMBL2008928 0.88 AOC3 (0.42) ITGB3ITGA2BMAPTPRMT5WDR77
SCHEMBL2007269 0.86 ITGB3 (0.42) ITGB3ITGA2BMAPTL3MBTL1AOC3
SCHEMBL2010513 0.86 ITGB3 (0.51) ITGB3ITGA2BMAPTAOC3KDM4E
SCHEMBL2011666 0.85 ITGB3 (0.46) ITGB3ITGA2BMAPTPRMT5WDR77
SCHEMBL2010902 0.84 ITGB3 (0.41) ITGB3ITGA2BMAPTAOC3KDM4E
SCHEMBL2009998 0.84 ITGB3 (0.41) ITGB3ITGA2BMAPTL3MBTL1AOC3
SCHEMBL2009676 0.83 ITGB3 (0.41) ITGB3ITGA2BMAPTAOC3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7964628-B2 Fibrinogen receptor antagonists and their use PIRAMAL LIFE SCIENCES LIMITED (IN) 2011-06-21 US disclosed
US-20100256161-A1 FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE PIRAMAL LIFE SCIENCES LIMITED (IN) 2010-10-07 US disclosed
US-7759387-B2 Fibrinogen receptor antagonists and their use PIRAMAL LIFE SCIENCES LIMITED (IN) 2010-07-20 US disclosed
US-20070021489-A1 Fibrinogen receptor antagonists and their use NICHOLAS PIRAMAL INDIA LIMITED (IN) 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256161-A1 FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE FGB, F13B, F2 ITGB3 169/4885ITGA2B 63/4885MAPT 4727/4885
US-20070021489-A1 Fibrinogen receptor antagonists and their use FGB, F13B, F2 ITGB3 169/4885ITGA2B 63/4885MAPT 4727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.